SCHEMBL3660031

SCHEMBL3660031

CS(=O)(=O)C1CNCCN1C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.33
CA2 P00918 5/20 0.33
CA9 Q16790 5/20 0.33
CA4 P22748 4/20 0.33
CA12 O43570 1/20 0.31
ADRB1 P08588 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3253967 0.84 CA1 (0.32) CA1CA2CA9CA4
SCHEMBL3958464 0.84 CA1 (0.34) CA1CA2CA9CA4
SCHEMBL27947714 0.82 LMNA (0.35) CA1CA2CA9CA4CA12
SCHEMBL14837693 0.80 CA1 (0.33) CA1CA2CA9CA4
Hydrochloric Acid SCHEMBL5489333 0.80 CHRNB2 (0.37) CA1CA2CA9CA4
SCHEMBL20501449 0.75 RIPK1 (0.33)
SCHEMBL29947951 0.75 CA1 (0.38) CA1CA2CA9CA4ADRB1
SCHEMBL15225968 0.75 LMNA (0.48)
SCHEMBL6744243 0.74 CA1 (0.44) CA1CA2CA9CA4
SCHEMBL5678515 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2828253-A1 CARBAMATE COMPOUNDS AND OF MAKING AND USING SAME Abide Therapeutics, Inc. (US) 2015-01-28 EP claimed
WO-2013142307-A1 CARBAMATE COMPOUNDS AND OF MAKING AND USING SAME ABIDE THERAPEUTICS (US) 2013-09-26 WO claimed
WO-2024259171-A2 KEAP1 INHIBITORS AND USES THEREOF VIVIDION THERAPEUTICS, INC. (US) 2024-12-19 WO disclosed
EP-2212333-A1 THIENOPYRIMIDINE AND PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS Wyeth LLC (US) 2010-08-04 EP disclosed
WO-2009052145-A1 THIENOPYRIMIDINE AND PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS WYETH (US) 2009-04-23 WO disclosed